IREN
IREN Limited
There isn't enough reported data to score IREN yet.
QCRH
QCR Holdings, Inc.
QCRH's fundamentals are strong, but it looks expensive: trading at 12x earnings, above its usual 10x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
QCRH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
QCRH's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like QCRH.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
QCRH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $69.92 | -32% |
| Fair | 10x | $85.51 | -17% |
| Expensive | 12x | $99.81 | -3.4% |
| Current | 12x | $103 | — |
| Forward | 12x | $103 | — |
Historical ranges are pointers, not guarantees.
QCRH's PE is in its expensive range at 12.2x. If earnings grow as analysts expect, today's price would be 11.6x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
QCRH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
QCRH has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
QCRH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.94 | +5.3% |
| Q3 2026 | $8.49 | +19% |
| Q2 2026 | $8.44 | +27% |
| Q1 2026 | $7.96 | +20% |
| Q4 2025 | $7.49 | +12% |
| Q3 2025 | $7.16 | +3.9% |
| Q2 2025 | $6.64 | -1.5% |
| Q1 2025 | $6.65 | -0.9% |
| Q4 2024 | $6.71 | -0.3% |
QCRH has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over QCRH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
QCRH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $99.2M | -2.2% |
| Q2 2026 | $97.3M | +16% |
| Q1 2026 | $90.4M | +18% |
| Q4 2025 | $107M | +17% |
| Q3 2025 | $101.5M | +17% |
| Q2 2025 | $84.2M | -3.3% |
| Q1 2025 | $76.9M | -5.7% |
| Q4 2024 | $91.8M | -11% |
QCRH's revenue has picked up after two years of holding roughly level: $99M last quarter, down 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +0.4 points |
| Q2 2026 | 41% | +4.3 points |
| Q1 2026 | 40% | +5.7 points |
| Q4 2025 | 36% | 0 points |
| Q3 2025 | 40% | +5.6 points |
| Q2 2025 | 36% | -0.1 points |
| Q1 2025 | 34% | -0.3 points |
| Q4 2024 | 36% | +0.1 points |
QCRH has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
QCRH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.9M | -63% |
| Q2 2026 | $458.1M | +1792% |
| Q1 2026 | -$7.9M | +$4.8M |
| Q4 2025 | $310.8M | +90% |
| Q3 2025 | $31.7M | -86% |
| Q2 2025 | $24.2M | +50% |
| Q1 2025 | -$12.7M | -$3.3M |
| Q4 2024 | $163.4M | -42% |
QCRH has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
QCRH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -119K shares |
| 1 year | -3.3% | -565K shares |
| 3 years | -2.4% | -397K shares |
| 5 years | +3.7% | +581K shares |
| Available history | +3% | +483K shares |
QCRH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
QCRH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Moderate |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.1x | Healthy |
QCRH's net debt is about 1.5 years of its operating earnings (EBITDA), down from 2.0 years a year ago. Net leverage isn't a meaningful measure for financial services companies like QCRH.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
QCRH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 49.4 | Neutral |
QCRH's weekly RSI is 59 (neutral) and its Stochastic is 49 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
QCRH PE vs Financial Services Sector
| Metric | QCRH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 6.5% below |
| PE % | 91 | 63 | 28 pts above |
QCRH is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
QCRH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.9 | 2.5% above |
| 20 week MA | $101.0 | 2.4% above |
| 50 week MA | $93.7 | 10% above |
| 100 week MA | $83.6 | 24% above |
| 200 week MA | $70.6 | 46% above |
QCRH has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
QCRH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.3 | $39.7 | -8.4% |
| 2021 | $39.7 | $55.3 | +39% |
| 2022 | $55.3 | $50.0 | -9.7% |
| 2023 | $50.0 | $58.4 | +17% |
| 2024 | $58.4 | $80.8 | +38% |
| 2025 | $80.8 | $84.8 | +4.9% |
| 2026 YTD | $84.8 | $103.4 | +22% |
QCRH has the edge over IREN on returns for 2026, with the stronger performance.